等待开盘 11-06 09:30:00 美东时间
-2.280
-2.55%
Solventum (NYSE: SOLV), a leader in advanced wound healing, announced today that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the combined use of Restrata™ Synthetic Electrospun Fiber Matrix and Solventum™ V.A.C.® Therapy*. Following Solventum's acquisition of Acera S...
10-20 04:07
First-of-its-kind clearance combines two advanced wound care technologies into one path for active healing to help streamline care and improve patient outcomes Clearance pairs innovative syn...
10-20 04:05
Solventum (SOLV), the 3M (MMM) spinoff that manufactures medical products and technology, is collecting initial offers for its Health Information Systems unit. The business, which provides hospitals w...
10-12 23:24
(来源:医疗器械创新网) 注:各大公司财政年度的起始时间不同于自然年,因此会出现财政季度、年度等与自然年不一致的情况。各家公司可能会按照每季度、每半年的频率公布...
09-20 16:58
今日重点评级关注:Ascendiant Capital:维持SurgePays"买入"评级,目标价从3.5美元升至3.75美元;HC Wainwright & Co.:维持Spero Therapeutics"买入"评级,目标价从5美元升至6美元
09-15 15:30
BTIG analyst Ryan Zimmerman reiterates Solventum (NYSE:SOLV) with a Buy and maintains $95 price target.
09-14 18:29
Curreen Capital gained 22.26% in Q2, outperforming the S&P 500's 15.20% return and MSCI World's 13.83%. During Q2 2026, the fund bought a new position in Optimum Communications (NYSE: OPTU) and Green ...
08-11 22:08
今日重点评级关注:康托·菲茨杰拉德:维持EyePoint"超配"评级,目标价从47美元升至55美元;伯恩斯坦:维持Figure Technology"跑赢大市"评级,目标价从67美元升至70美元
08-07 13:41
BTIG analyst Ryan Zimmerman maintains Solventum (NYSE:SOLV) with a Buy and raises the price target from $91 to $95.
08-06 17:49
华盛资讯8月6日讯,Solventum Corporation公布2026财年Q2业绩,公司Q2营收22.09亿美元,同比增长2.2%,归母净利润0.92亿美元,同比增长2.2%。
08-06 06:57